ResearcherInsermNo recent work listed
Éric Raymond
Matched on ORCID iD 0000-0001-5491-2708; OpenAlex author ID A5013952219. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 18
2013: 2 papers · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: 1 paper
Papers 5
- Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer. Co-author DOI 10.1002/ijc.31603↗
- High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis. Co-author DOI 10.1111/his.12691↗
- Targeting cancer cell metabolism in pancreatic adenocarcinoma. Last author DOI 10.18632/oncotarget.4160↗
- Targeting the Ras-ERK pathway in pancreatic adenocarcinoma. Last author DOI 10.1007/s10555-012-9396-2↗
- Stromal expression of SPARC in pancreatic adenocarcinoma. Last author DOI 10.1007/s10555-013-9439-3↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pascal R. Hammel · 4 shared papers, 2013–2018 · strength 0.20
- Paper Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer. DOI 10.1002/ijc.31603↗
- Paper Targeting the Ras-ERK pathway in pancreatic adenocarcinoma. DOI 10.1007/s10555-012-9396-2↗
- Paper High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correl… DOI 10.1111/his.12691↗
- Annemilaï Tijeras‐Raballand · 4 shared papers, 2013–2015 · strength 0.19
- Paper Targeting cancer cell metabolism in pancreatic adenocarcinoma. DOI 10.18632/oncotarget.4160↗
- Paper Targeting the Ras-ERK pathway in pancreatic adenocarcinoma. DOI 10.1007/s10555-012-9396-2↗
- Paper High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correl… DOI 10.1111/his.12691↗
- Cindy Neuzillet · 4 shared papers, 2013–2015 · strength 0.19
- Paper Targeting cancer cell metabolism in pancreatic adenocarcinoma. DOI 10.18632/oncotarget.4160↗
- Paper Targeting the Ras-ERK pathway in pancreatic adenocarcinoma. DOI 10.1007/s10555-012-9396-2↗
- Paper High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correl… DOI 10.1111/his.12691↗
- Anne Couvelard · 2 shared papers, 2013–2015 · strength 0.09
- Jerome F. Cros · 2 shared papers, 2013–2015 · strength 0.09
- Nebojsa S. Manojlovic · 1 shared paper, 2018 · strength 0.07
- Chris Verslype · 1 shared paper, 2018 · strength 0.07
- Manuel M. Hidalgo · 1 shared paper, 2018 · strength 0.07
- Dejan V. Radenkovic · 1 shared paper, 2018 · strength 0.07
- Antonio Cubillo · 1 shared paper, 2018 · strength 0.07
- Eric Van Cutsem · 1 shared paper, 2018 · strength 0.07
- Teresa Mercade Macarulla · 1 shared paper, 2018 · strength 0.07
- Romain Cohen · 1 shared paper, 2015 · strength 0.06
- Philippe B Ruszniewski · 1 shared paper, 2015 · strength 0.04
- Alain Sauvanet · 1 shared paper, 2015 · strength 0.04
- Valérie Paradis · 1 shared paper, 2015 · strength 0.04
- Louis de Mestier · 1 shared paper, 2015 · strength 0.04
- Jean‐Baptiste Bachet · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.